Literature DB >> 1698186

A microcytofluorometric method for quantitative and qualitative evaluation of CFU-E and BFU-E colonies.

N Maruo1, M Ozawa, M Kondo, S Fujita.   

Abstract

A new method has been developed for the precise identification of human bone marrow colony forming unit erythroid (CFU-E) and burst forming unit erythroid (BFU-E) colonies, and for determination of the hemoglobin contents using microcytofluorometry. The method relies on a photochemical reaction in which intracellular hemoglobin is converted into fluorescent porphyrin under violet light (lambda = 405 nm) in the presence of an SH-donor (mercaptoethylamine hydrochloride). The CFU-E and BFU-E colonies showed red fluorescence with two spectrum peaks at 600 and 650 nm when illuminated by violet light. These two peaks are consistent with those of porphyrin fluorescence. The porphyrin fluorescence was not inducible in colony forming unit granulocyte-macrophage (CFU-GM) colonies, while 20% of the CFU-GM colonies were false positive with respect to the conventional benzidine reaction. The photochemically inducible fluorescence began to appear in BFU-E colonies on the 4th day of culture, while the same colonies started to be positive for the benzidine reaction on the 9th day. Therefore, the photochemical reaction was more specific and sensitive than the benzidine reaction for the identification of CFU-E and BFU-E colonies. In addition, this method enabled us to measure the hemoglobin level in the cells forming the colonies because the intensity of the fluorescence was proportional to the amount of hemoglobin when the photochemical reaction was carried out for 50 min.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698186     DOI: 10.1007/bf00266625

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  15 in total

1.  Fetal hemoglobin in mixed hemopoietic colonies (CFU-GEMM), erythroid bursts (BFU-E) and erythroid colonies (CFU-E): assessment by radioimmune assay and immunofluorescence.

Authors:  A A Fauser; H A Messner
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

2.  Morphological features and erythropoietin sensitivity of the most primitive erythroid cell.

Authors:  N Maruo; M Kondo; S Fujita; M Fukuda
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1988-02

3.  Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro.

Authors:  J R Stephenson; A A Axelrad; D L McLeod; M M Shreeve
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

4.  Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.

Authors:  N N Iscove; F Sieber; K H Winterhalter
Journal:  J Cell Physiol       Date:  1974-04       Impact factor: 6.384

5.  [Androgenotherapy of dysmyelopoietic syndrome (author's transl)].

Authors:  S Mitsutani; S Hiraide
Journal:  Rinsho Ketsueki       Date:  1982-01

6.  Circulating erythropoietic precursors assessed in culture: characterization in normal men and patients with hemoglobinopathies.

Authors:  M Ogawa; O C Grush; R F O'Dell; H Hara; M D MacEachern
Journal:  Blood       Date:  1977-12       Impact factor: 22.113

7.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

8.  Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.

Authors:  S Eridani; L C Chan; O Halil; T C Pearson
Journal:  Br J Haematol       Date:  1985-11       Impact factor: 6.998

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.

Authors:  K Geissler; W Hinterberger; U Jäger; P Bettelheim; E Neumann; O Haas; P Ambros; A Chott; T Radaszkiewicz; K Lechner
Journal:  Blut       Date:  1988-07
View more
  1 in total

1.  A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.

Authors:  Xiao-hui Shen; Nan-nan Sun; Ya-fei Yin; Su-fang Liu; Xiao-liu Liu; Hong-ling Peng; Chong-wen Dai; Yun-xiao Xu; Ming-yang Deng; Yun-ya Luo; Wen-li Zheng; Guang-sen Zhang
Journal:  Oncotarget       Date:  2016-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.